Granite Point Capital Management, L.P. - EVAXION BIOTECH A S ownership

EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 8 filers reported holding EVAXION BIOTECH A S in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of EVAXION BIOTECH A S
ValueSharesWeighting
Q2 2021$911,000
-31.2%
117,690
-47.6%
0.03%
-30.6%
Q1 2021$1,325,000224,6010.05%
Other shareholders
EVAXION BIOTECH A S shareholders Q3 2021
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 30,743$296,0000.40%
Maven Securities LTD 222,806$2,148,0000.07%
Kepos Capital LP 37,098$358,0000.02%
ETF MANAGERS GROUP, LLC 6,859$64,0000.00%
CREDIT SUISSE AG/ 40,315$389,0000.00%
MORGAN STANLEY 200$2,0000.00%
UBS Group AG 2,261$22,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EVAXION BIOTECH A S shareholders